 | • レポートコード：QYR9ST05474 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥518,000 (USD3,500) | ▷ お問い合わせ |
| Enterprise License | ￥1,036,000 (USD7,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートは、エプチフィバチドの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、0.75mg / ml、2mg / mlに、用途別には、不安定狭心症、心筋梗塞、その他にセグメント区分し、エプチフィバチドの世界市場を分析しました。 ・エグゼクティブ・サマリー ・エプチフィバチドの世界市場概要 ・エプチフィバチドの製造コスト構成分析 ・エプチフィバチドの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・エプチフィバチドの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・エプチフィバチドのセグメント分析（種類別） （0.75mg / ml、2mg / ml） ・エプチフィバチドのセグメント分析（用途別） （不安定狭心症、心筋梗塞、その他） ・エプチフィバチドの主要メーカー別分析（生産拠点、製品概要、生産・売上実績） （Merck、Taj Pharmaceuticals、Cigna、Gland Pharma、AuroMedics Pharma、Millennium Pharmaceuticals、Hybio Pharmaceutical、GlaxoSmithKline、Schering-Plough Corporation、Novetide） ・エプチフィバチドの市場規模予測（2019年～2025年） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・マーケティングチャネル・流通業者・顧客 ・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子） ... |
The global Eptifibatide market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Eptifibatide volume and value at global level, regional level and company level. From a global perspective, this report represents overall Eptifibatide market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Eptifibatide in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Eptifibatide manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Merck
Taj Pharmaceuticals
Cigna
Gland Pharma
AuroMedics Pharma
Millennium Pharmaceuticals
Hybio Pharmaceutical
GlaxoSmithKline
Schering-Plough Corporation
Novetide
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
0.75mg/ml
2mg/ml
Segment by Application
Unstable Angina
Myocardial Infarction
Other
Table of Contents
Executive Summary
1 Industry Overview of Eptifibatide
1.1 Definition of Eptifibatide
1.2 Eptifibatide Segment by Type
1.2.1 Global Eptifibatide Production Growth Rate Comparison by Types (2014-2025)
1.2.2 0.75mg/ml
1.2.3 2mg/ml
1.3 Eptifibatide Segment by Applications
1.3.1 Global Eptifibatide Consumption Comparison by Applications (2014-2025)
1.3.2 Unstable Angina
1.3.3 Myocardial Infarction
1.3.4 Other
1.4 Global Eptifibatide Overall Market
1.4.1 Global Eptifibatide Revenue (2014-2025)
1.4.2 Global Eptifibatide Production (2014-2025)
1.4.3 North America Eptifibatide Status and Prospect (2014-2025)
1.4.4 Europe Eptifibatide Status and Prospect (2014-2025)
1.4.5 China Eptifibatide Status and Prospect (2014-2025)
1.4.6 Japan Eptifibatide Status and Prospect (2014-2025)
1.4.7 Southeast Asia Eptifibatide Status and Prospect (2014-2025)
1.4.8 India Eptifibatide Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Eptifibatide
2.3 Manufacturing Process Analysis of Eptifibatide
2.4 Industry Chain Structure of Eptifibatide
3 Development and Manufacturing Plants Analysis of Eptifibatide
3.1 Capacity and Commercial Production Date
3.2 Global Eptifibatide Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Eptifibatide
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Eptifibatide Production and Capacity Analysis
4.2 Eptifibatide Revenue Analysis
4.3 Eptifibatide Price Analysis
4.4 Market Concentration Degree
5 Eptifibatide Regional Market Analysis
5.1 Eptifibatide Production by Regions
5.1.1 Global Eptifibatide Production by Regions
5.1.2 Global Eptifibatide Revenue by Regions
5.2 Eptifibatide Consumption by Regions
5.3 North America Eptifibatide Market Analysis
5.3.1 North America Eptifibatide Production
5.3.2 North America Eptifibatide Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Eptifibatide Import and Export
5.4 Europe Eptifibatide Market Analysis
5.4.1 Europe Eptifibatide Production
5.4.2 Europe Eptifibatide Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Eptifibatide Import and Export
5.5 China Eptifibatide Market Analysis
5.5.1 China Eptifibatide Production
5.5.2 China Eptifibatide Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Eptifibatide Import and Export
5.6 Japan Eptifibatide Market Analysis
5.6.1 Japan Eptifibatide Production
5.6.2 Japan Eptifibatide Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Eptifibatide Import and Export
5.7 Southeast Asia Eptifibatide Market Analysis
5.7.1 Southeast Asia Eptifibatide Production
5.7.2 Southeast Asia Eptifibatide Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Eptifibatide Import and Export
5.8 India Eptifibatide Market Analysis
5.8.1 India Eptifibatide Production
5.8.2 India Eptifibatide Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Eptifibatide Import and Export
6 Eptifibatide Segment Market Analysis (by Type)
6.1 Global Eptifibatide Production by Type
6.2 Global Eptifibatide Revenue by Type
6.3 Eptifibatide Price by Type
7 Eptifibatide Segment Market Analysis (by Application)
7.1 Global Eptifibatide Consumption by Application
7.2 Global Eptifibatide Consumption Market Share by Application (2014-2019)
8 Eptifibatide Major Manufacturers Analysis
8.1 Merck
8.1.1 Merck Eptifibatide Production Sites and Area Served
8.1.2 Merck Product Introduction, Application and Specification
8.1.3 Merck Eptifibatide Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Taj Pharmaceuticals
8.2.1 Taj Pharmaceuticals Eptifibatide Production Sites and Area Served
8.2.2 Taj Pharmaceuticals Product Introduction, Application and Specification
8.2.3 Taj Pharmaceuticals Eptifibatide Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Cigna
8.3.1 Cigna Eptifibatide Production Sites and Area Served
8.3.2 Cigna Product Introduction, Application and Specification
8.3.3 Cigna Eptifibatide Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Gland Pharma
8.4.1 Gland Pharma Eptifibatide Production Sites and Area Served
8.4.2 Gland Pharma Product Introduction, Application and Specification
8.4.3 Gland Pharma Eptifibatide Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 AuroMedics Pharma
8.5.1 AuroMedics Pharma Eptifibatide Production Sites and Area Served
8.5.2 AuroMedics Pharma Product Introduction, Application and Specification
8.5.3 AuroMedics Pharma Eptifibatide Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Millennium Pharmaceuticals
8.6.1 Millennium Pharmaceuticals Eptifibatide Production Sites and Area Served
8.6.2 Millennium Pharmaceuticals Product Introduction, Application and Specification
8.6.3 Millennium Pharmaceuticals Eptifibatide Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Hybio Pharmaceutical
8.7.1 Hybio Pharmaceutical Eptifibatide Production Sites and Area Served
8.7.2 Hybio Pharmaceutical Product Introduction, Application and Specification
8.7.3 Hybio Pharmaceutical Eptifibatide Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 GlaxoSmithKline
8.8.1 GlaxoSmithKline Eptifibatide Production Sites and Area Served
8.8.2 GlaxoSmithKline Product Introduction, Application and Specification
8.8.3 GlaxoSmithKline Eptifibatide Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Schering-Plough Corporation
8.9.1 Schering-Plough Corporation Eptifibatide Production Sites and Area Served
8.9.2 Schering-Plough Corporation Product Introduction, Application and Specification
8.9.3 Schering-Plough Corporation Eptifibatide Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Novetide
8.10.1 Novetide Eptifibatide Production Sites and Area Served
8.10.2 Novetide Product Introduction, Application and Specification
8.10.3 Novetide Eptifibatide Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
9 Development Trend of Analysis of Eptifibatide Market
9.1 Global Eptifibatide Market Trend Analysis
9.1.1 Global Eptifibatide Market Size (Volume and Value) Forecast 2019-2025
9.2 Eptifibatide Regional Market Trend
9.2.1 North America Eptifibatide Forecast 2019-2025
9.2.2 Europe Eptifibatide Forecast 2019-2025
9.2.3 China Eptifibatide Forecast 2019-2025
9.2.4 Japan Eptifibatide Forecast 2019-2025
9.2.5 Southeast Asia Eptifibatide Forecast 2019-2025
9.2.6 India Eptifibatide Forecast 2019-2025
9.3 Eptifibatide Market Trend (Product Type)
9.4 Eptifibatide Market Trend (Application)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Eptifibatide Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
Figure Picture of Eptifibatide
Table Global Eptifibatide Production (K Units) Growth Rate Comparison by Types (2014-2025)
Figure Global Eptifibatide Production Market Share by Types in 2018
Figure 0.75mg/ml Product Picture
Figure 2mg/ml Product Picture
Table Global Eptifibatide Consumption (K Units) Comparison by Applications (2014-2025)
Figure Global Eptifibatide Consumption Market Share by Applications in 2018
Figure Unstable Angina
Figure Myocardial Infarction
Figure Other
Figure Global Eptifibatide Revenue (Million USD) (2014-2025)
Figure Global Eptifibatide Production (K Units) (2014-2025)
Figure North America Eptifibatide Market Size (Million USD) (2014-2025)
Figure Europe Eptifibatide Market Size (Million USD) (2014-2025)
Figure China Eptifibatide Market Size (Million USD) (2014-2025)
Figure Japan Eptifibatide Market Size (Million USD) (2014-2025)
Figure Southeast Asia Eptifibatide Market Size (Million USD) (2014-2025)
Figure India Eptifibatide Market Size (Million USD) (2014-2025)
Table Eptifibatide Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Eptifibatide in 2018
Figure Manufacturing Process Analysis of Eptifibatide
Figure Industry Chain Structure of Eptifibatide
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Eptifibatide Manufacturing Plants Distribution
Table Eptifibatide Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Eptifibatide Capacity (K Units) of Major Manufacturers (2014-2019)
Table Eptifibatide Production (K Units) of Major Manufacturers (2014-2019)
Table Eptifibatide Production Market Share of Major Manufacturers (2014-2019)
Figure Eptifibatide Production Share by Manufacturers in 2018
Table Eptifibatide Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Eptifibatide Revenue Market Share of Major Manufacturers (2014-2019)
Figure Eptifibatide Revenue Share by Manufacturers in 2018
Table Eptifibatide Average Price (USD/Unit) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Eptifibatide Production by Regions 2014-2019 (K Units)
Table Global Eptifibatide Production Market Share by Regions 2014-2019
Figure Global Eptifibatide Production Market Share by Regions in 2018
Table Global Eptifibatide Revenue by Regions 2014-2019 (Million USD)
Table Global Eptifibatide Revenue Market Share by Regions 2014-2019
Figure Global Eptifibatide Revenue Market Share by Regions in 2018
Table Global Eptifibatide Consumption by Regions 2014-2019 (K Units)
Table Global Eptifibatide Consumption Market Share by Regions 2014-2019
Figure North America Eptifibatide Production Growth Rate 2014-2019 (K Units)
Figure North America Eptifibatide Revenue Growth Rate 2014-2019 (Million USD)
Table North America Eptifibatide Production, Consumption Import and Export (K Units)
Figure Europe Eptifibatide Production Growth Rate 2014-2019 (K Units)
Figure Europe Eptifibatide Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Eptifibatide Production, Consumption Import and Export (K Units)
Figure China Eptifibatide Production Growth Rate 2014-2019 (K Units)
Figure China Eptifibatide Revenue Growth Rate 2014-2019 (Million USD)
Table China Eptifibatide Production, Consumption Import and Export (K Units)
Figure Japan Eptifibatide Production Growth Rate 2014-2019 (K Units)
Figure Japan Eptifibatide Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Eptifibatide Production, Consumption Import and Export (K Units)
Figure Southeast Asia Eptifibatide Production Growth Rate 2014-2019 (K Units)
Figure Southeast Asia Eptifibatide Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Eptifibatide Production, Consumption Import and Export (K Units)
Figure India Eptifibatide Production Growth Rate 2014-2019 (K Units)
Figure India Eptifibatide Revenue Growth Rate 2014-2019 (Million USD)
Table India Eptifibatide Production, Consumption Import and Export (K Units)
Figure Global Consumption Eptifibatide Market Share by Application (2014-2019)
Figure Global Value (Consumption) Eptifibatide Market Share by Application (2014-2019)
Table Merck Eptifibatide Production Sites and Area Served
Table Merck Eptifibatide Product Introduction, Application and Specification
Table Merck Eptifibatide Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Merck Eptifibatide Production Growth Rate (2014-2019)
Table Merck Eptifibatide Production Market Share (2014-2019)
Figure Merck Eptifibatide Revenue Market Share (2014-2019)
Table Merck Eptifibatide Main Business and Markets Served
Table Taj Pharmaceuticals Eptifibatide Production Sites and Area Served
Table Taj Pharmaceuticals Eptifibatide Product Introduction, Application and Specification
Table Taj Pharmaceuticals Eptifibatide Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Taj Pharmaceuticals Eptifibatide Production Growth Rate (2014-2019)
Table Taj Pharmaceuticals Eptifibatide Production Market Share (2014-2019)
Figure Taj Pharmaceuticals Eptifibatide Revenue Market Share (2014-2019)
Table Taj Pharmaceuticals Eptifibatide Main Business and Markets Served
Table Cigna Eptifibatide Production Sites and Area Served
Table Cigna Eptifibatide Product Introduction, Application and Specification
Table Cigna Eptifibatide Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Cigna Eptifibatide Production Growth Rate (2014-2019)
Table Cigna Eptifibatide Production Market Share (2014-2019)
Figure Cigna Eptifibatide Revenue Market Share (2014-2019)
Table Cigna Eptifibatide Main Business and Markets Served
Table Gland Pharma Eptifibatide Production Sites and Area Served
Table Gland Pharma Eptifibatide Product Introduction, Application and Specification
Table Gland Pharma Eptifibatide Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Gland Pharma Eptifibatide Production Growth Rate (2014-2019)
Table Gland Pharma Eptifibatide Production Market Share (2014-2019)
Figure Gland Pharma Eptifibatide Revenue Market Share (2014-2019)
Table Gland Pharma Eptifibatide Main Business and Markets Served
Table AuroMedics Pharma Eptifibatide Production Sites and Area Served
Table AuroMedics Pharma Eptifibatide Product Introduction, Application and Specification
Table AuroMedics Pharma Eptifibatide Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table AuroMedics Pharma Eptifibatide Production Growth Rate (2014-2019)
Table AuroMedics Pharma Eptifibatide Production Market Share (2014-2019)
Figure AuroMedics Pharma Eptifibatide Revenue Market Share (2014-2019)
Table AuroMedics Pharma Eptifibatide Main Business and Markets Served
Table Millennium Pharmaceuticals Eptifibatide Production Sites and Area Served
Table Millennium Pharmaceuticals Eptifibatide Product Introduction, Application and Specification
Table Millennium Pharmaceuticals Eptifibatide Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Millennium Pharmaceuticals Eptifibatide Production Growth Rate (2014-2019)
Table Millennium Pharmaceuticals Eptifibatide Production Market Share (2014-2019)
Figure Millennium Pharmaceuticals Eptifibatide Revenue Market Share (2014-2019)
Table Millennium Pharmaceuticals Eptifibatide Main Business and Markets Served
Table Hybio Pharmaceutical Eptifibatide Production Sites and Area Served
Table Hybio Pharmaceutical Eptifibatide Product Introduction, Application and Specification
Table Hybio Pharmaceutical Eptifibatide Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Hybio Pharmaceutical Eptifibatide Production Growth Rate (2014-2019)
Table Hybio Pharmaceutical Eptifibatide Production Market Share (2014-2019)
Figure Hybio Pharmaceutical Eptifibatide Revenue Market Share (2014-2019)
Table Hybio Pharmaceutical Eptifibatide Main Business and Markets Served
Table GlaxoSmithKline Eptifibatide Production Sites and Area Served
Table GlaxoSmithKline Eptifibatide Product Introduction, Application and Specification
Table GlaxoSmithKline Eptifibatide Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table GlaxoSmithKline Eptifibatide Production Growth Rate (2014-2019)
Table GlaxoSmithKline Eptifibatide Production Market Share (2014-2019)
Figure GlaxoSmithKline Eptifibatide Revenue Market Share (2014-2019)
Table GlaxoSmithKline Eptifibatide Main Business and Markets Served
Table Schering-Plough Corporation Eptifibatide Production Sites and Area Served
Table Schering-Plough Corporation Eptifibatide Product Introduction, Application and Specification
Table Schering-Plough Corporation Eptifibatide Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Schering-Plough Corporation Eptifibatide Production Growth Rate (2014-2019)
Table Schering-Plough Corporation Eptifibatide Production Market Share (2014-2019)
Figure Schering-Plough Corporation Eptifibatide Revenue Market Share (2014-2019)
Table Schering-Plough Corporation Eptifibatide Main Business and Markets Served
Table Novetide Eptifibatide Production Sites and Area Served
Table Novetide Eptifibatide Product Introduction, Application and Specification
Table Novetide Eptifibatide Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Novetide Eptifibatide Production Growth Rate (2014-2019)
Table Novetide Eptifibatide Production Market Share (2014-2019)
Figure Novetide Eptifibatide Revenue Market Share (2014-2019)
Table Novetide Eptifibatide Main Business and Markets Served
Figure Global Eptifibatide Production (K Units) Growth Rate Forecast 2019-2025
Figure Global Eptifibatide Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Eptifibatide Sales Price (USD/Unit) Forecast 2019-2025
Figure North America Eptifibatide Production Growth Rate Forecast 2019-2025 (K Units)
Figure North America Eptifibatide Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Eptifibatide Production Growth Rate Forecast 2019-2025 (K Units)
Figure Europe Eptifibatide Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Eptifibatide Production Growth Rate Forecast 2019-2025 (K Units)
Figure China Eptifibatide Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Eptifibatide Production Growth Rate Forecast 2019-2025 (K Units)
Figure Japan Eptifibatide Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Eptifibatide Production Growth Rate Forecast 2019-2025 (K Units)
Figure Southeast Asia Eptifibatide Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Eptifibatide Production Growth Rate Forecast 2019-2025 (K Units)
Figure India Eptifibatide Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Units) of Eptifibatide by Type (2019-2025)
Table Global Consumption (K Units) of Eptifibatide by Application (2019-2025)
Table Eptifibatide Distributors List
Table Eptifibatide Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界のエプチフィバチド市場：専門的調査 The global Eptifibatide market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report focuses on Eptifibatide volume and value at global level, regional level and company level. From a global perspective, this rep…- ペプチドベース心血管治療薬の世界市場：市場規模・現状・予測 Cardiovascular disease (CVD) is a class of diseases that involve the heart or blood vessels. Cardiovascular disease includes coronary artery diseases (CAD) such as angina and myocardial infarction (commonly known as a heart attack). Other CVDs include stroke, heart failure, hypertensive heart diseas…
- 虚血性心疾患（IHD）医薬品の世界市場：インサイト・予測 Ischemic heart disease (IHD), refers to a group of diseases which includes stable angina, unstable angina, myocardial infarction, and sudden cardiac death. It is within the group of cardiovascular diseases of which it is the most common type. A common symptom is chest pain or discomfort which may tr…
- 心臓トロポニンの世界市場：インサイト・予測 Cardiac troponins are one of the cardiac biomarkers or diagnostic markers centralized to myocardial infarction or heart muscle cell death diagnosis.Troponin is found in skeletal muscle and cardiac muscle of human body, thus increased level of the cardiac troponin circulating in the blood represents …
- 世界のドブタミン市場：専門的調査 The global Dobutamine market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report focuses on Dobutamine volume and value at global level, regional level and company level. From a global perspective, this report …